Form 4 for HBIO HARVARD BIOSCIENCE INC
Accepted 2022-07-20 00:00:00 ET · period of report 2022-07-18 · accession 0000921895-22-002258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-20 | 2022-07-18 | HBIO | Rossi Michael A. | CFO | F - Tax | $3.63 | -7,008 | 270.5K | -3% | -$25.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-18 | F | D | 7,008 | $3.63 | 270,500 | D | — | — | (F1) The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person that fully vested on July 18, 2022. (F2) Include (a) 31,021 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (b) 21,545 remaining restricted stock units that will vest on June 11, 2023, (c) 25,641 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 65,592 restricted stock units with performance based vesting conditions, (e) 21,545 remaining restricted stock units that will vest on December 29, 2022 and 2023, and (f) 105,156 shares of common stock beneficially owned by the Reporting Person. |